|
1
|
Teerapuncharoen K and Bag R: Chronic
thromboembolic pulmonary hypertension. Lung. 200:283–299.
2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Galiè N, Humbert M, Vachiery J, Gibbs S,
Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A,
Beghetti M, et al: 2015 ESC/ERS guidelines for the diagnosis and
treatment of pulmonary hypertension. Rev Esp Cardiol (Engl Ed).
69(177)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Delcroix M, Lang I, Pepke-Zaba J, Jansa P,
D'Armini A, Snijder R, Bresser P, Torbicki A, Mellemkjaer S,
Lewczuk J, et al: Long-term outcome of patients with chronic
thromboembolic pulmonary hypertension: Results from an
international prospective registry. Circulation. 133:859–871.
2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pepke-Zaba J, Delcroix M, Lang I, Mayer E,
Jansa P, Ambroz D, Treacy C, D'Armini A, Morsolini M, Snijder R, et
al: Chronic thromboembolic pulmonary hypertension (cteph): Results
from an international prospective registry. Circulation.
124:1973–1981. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mizoguchi H, Ogawa A, Munemasa M, Mikouchi
H, Ito H and Matsubara H: Refined balloon pulmonary angioplasty for
inoperable patients with chronic thromboembolic pulmonary
hypertension. Circ Cardiovasc Interv. 5:748–755. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Bitker L, Sens F, Payet C, Turquier S,
Duclos A, Cottin V and Juillard L: Presence of kidney disease as an
outcome predictor in patients with pulmonary arterial hypertension.
Am J Nephrol. 47:134–143. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shah S, Thenappan T, Rich S, Tian L,
Archer S and Gomberg-Maitland M: Association of serum creatinine
with abnormal hemodynamics and mortality in pulmonary arterial
hypertension. Circulation. 117:2475–2483. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Andreassen A, Ragnarsson A, Gude E, Geiran
O and Andersen R: Balloon pulmonary angioplasty in patients with
inoperable chronic thromboembolic pulmonary hypertension. Heart.
99:1415–1420. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Srisawasdi P, Vanavanan S,
Charoenpanichkit C and Kroll M: The effect of renal dysfunction on
bnp, nt-probnp, and their ratio. Am J Clin Pathol. 133:14–23.
2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Anwaruddin S, Lloyd-Jones DM, Baggish A,
Chen A, Krauser D, Tung R, Chae C and Januzzi JL Jr: Renal
function, congestive heart failure, and amino-terminal pro-brain
natriuretic peptide measurement: Results from the ProBNP
Investigation of Dyspnea in the Emergency Department (PRIDE) study.
J Am Coll Cardiol. 47:91–97. 2006.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang Y, Gu X, Fan W, Fan Y, Li W and Fu X:
Effects of recombinant human brain natriuretic peptide on renal
function in patients with acute heart failure following myocardial
infarction. Am J Transl Res. 8:239–245. 2016.PubMed/NCBI
|
|
12
|
Ogo T, Shimokawahara H, Kinoshita H, Sakao
S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, et al:
Selexipag for the treatment of chronic thromboembolic pulmonary
hypertension. Eur Respir J. 60(2101694)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Humbert M, Kovacs G, Hoeper MM,
Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS,
Escribano-Subias P, Ferrari P, et al: 2022 esc/ers guidelines for
the diagnosis and treatment of pulmonary hypertension. Eur Respir
J. 61:2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wiedenroth C, Ghofrani H, Adameit M,
Breithecker A, Haas M, Kriechbaum S, Rieth A, Hamm C, Mayer E, Guth
S and Liebetrau C: Sequential treatment with riociguat and balloon
pulmonary angioplasty for patients with inoperable chronic
thromboembolic pulmonary hypertension. Pulm Circ.
8(2045894018783996)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Galiè N, Humbert M, Vachiery JL, Gibbs S,
Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A,
Beghetti M, et al: 2015 ESC/ERS guidelines for the diagnosis and
treatment of pulmonary hypertension: The joint task force for the
diagnosis and treatment of pulmonary hypertension of the european
society of cardiology (ESC) and the european respiratory society
(ERS): Endorsed by: Association for european paediatric and
congenital cardiology (AEPC), international society for heart and
lung transplantation (ISHLT). Eur Heart J. 37:67–119.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
McConnell MV, Solomon SD, Rayan ME, Come
PC, Goldhaber SZ and Lee RT: Regional right ventricular dysfunction
detected by echocardiography in acute pulmonary embolism. Am J
Cardiol. 78:469–473. 1996.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Qu C, Feng W, Zhao Q, Liu Q, Luo X, Wang
G, Sun M, Yao Z, Sun Y, Hou S, et al: Effect of levosimendan on
acute decompensated right heart failure in patients with connective
tissue disease-associated pulmonary arterial hypertension. Front
Med. 9(778620)2022.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Olsson K, Wiedenroth C, Kamp J,
Breithecker A, Fuge J, Krombach G, Haas M, Hamm C, Kramm T, Guth S,
et al: Balloon pulmonary angioplasty for inoperable patients with
chronic thromboembolic pulmonary hypertension: The initial german
experience. Eur Respir J. 49(1602409)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Smilde T, van Veldhuisen D, Navis G, Voors
A and Hillege H: Drawbacks and prognostic value of formulas
estimating renal function in patients with chronic heart failure
and systolic dysfunction. Circulation. 114:1572–1580.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
National Kidney Foundation. K/DOQI
clinical practice guidelines for chronic kidney disease:
Evaluation, classification, and stratification. Am J Kidney Dis.
39(2 Suppl 1):S1–S266. 2002.PubMed/NCBI
|
|
21
|
Mehta R, Kellum J, Shah S, Molitoris B,
Ronco C, Warnock D and Levin A: Acute kidney injury network: Report
of an initiative to improve outcomes in acute kidney injury. Crit
Care. 11(R31)2007.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
Pistolesi V, Regolisti G, Morabito S,
Gandolfini I, Corrado S, Piotti G and Fiaccadori E: Contrast medium
induced acute kidney injury: A narrative review. J Nephrol.
31:797–812. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Manjunath G, Tighiouart H, Ibrahim H,
MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS and Sarnak MJ:
Level of kidney function as a risk factor for atherosclerotic
cardiovascular outcomes in the community. J Am Coll Cardiol.
41:47–55. 2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Damman K and Testani JM: The kidney in
heart failure: An update. Eur Heart J. 36:1437–1444.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Navaneethan SD, Wehbe E, Heresi GA, Gaur
V, Minai OA, Arrigain S, Nally JV Jr, Schold JD, Rahman M and Dweik
RA: Presence and outcomes of kidney disease in patients with
pulmonary hypertension. Clin J Am Soc Nephrol. 9:855–863.
2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Damman K, van Deursen VM, Navis G, Voors
AA, van Veldhuisen DJ and Hillege HL: Increased central venous
pressure is associated with impaired renal function and mortality
in a broad spectrum of patients with cardiovascular disease. J Am
Coll Cardiol. 53:582–588. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Felker GM, Adams KF, Konstam MA, O'Connor
CM and Gheorghiade M: The problem of decompensated heart failure:
Nomenclature, classification, and risk stratification. Am Heart J.
145:S18–S25. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Muller D and Liebetrau C: Percutaneous
treatment of chronic thromboembolic pulmonary hypertension (CTEPH).
EuroIntervention. 12 (Suppl X):X35–X43. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kimura M, Kataoka M, Kawakami T, Inohara
T, Takei M and Fukuda K: Balloon pulmonary angioplasty using
contrast agents improves impaired renal function in patients with
chronic thromboembolic pulmonary hypertension. Int J Cardiol.
188:41–42. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mullens W, Abrahams Z, Francis GS, Sokos
G, Taylor DO, Starling RC, Young JB and Tang WHW: Importance of
venous congestion for worsening of renal function in advanced
decompensated heart failure. J Am Coll Cardiol. 53:589–596.
2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Vonk-Noordegraaf A, Haddad F, Chin K,
Forfia P, Kawut S, Lumens J, Naeije R, Newman J, Oudiz R,
Provencher S, et al: Right heart adaptation to pulmonary arterial
hypertension: Physiology and pathobiology. J Am Coll Cardiol. 62
(Suppl 25):D22–D33. 2013.PubMed/NCBI
|
|
32
|
Kriechbaum S, Wiedenroth C, Hesse M,
Ajnwojner R, Keller T, Sebastian Wolter J, Haas M, Roller F,
Breithecker A, Rieth A, et al: Development of renal function during
staged balloon pulmonary angioplasty for inoperable chronic
thromboembolic pulmonary hypertension. Scand J Clin Lab Invest.
79:268–275. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li N, Jin H, Song Z, Bai C, Cui Y and Gao
Y: Protective effect of recombinant human brain natriuretic peptide
on acute renal injury induced by endotoxin in canines. Cell Biochem
Biophys. 70:1317–1324. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Miao Z, Hou A, Zang H, Huang R, Zheng X,
Lin H, Wang W, Hou P, Xia F and Li Z: Effects of recombinant human
brain natriuretic peptide on the prognosis of patients with acute
anterior myocardial infarction undergoing primary percutaneous
coronary intervention: A prospective, multi-center, randomized
clinical trial. J Thorac Dis. 9:54–63. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen H, Martin F, Gibbons R, Schirger J,
Wright R, Schears R, Redfield M, Simari R, Lerman A, Cataliotti A
and Burnett JC Jr: Low-dose nesiritide in human anterior myocardial
infarction suppresses aldosterone and preserves ventricular
function and structure: A proof of concept study. Heart.
95:1315–1319. 2009.PubMed/NCBI View Article : Google Scholar
|
